Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high-risk osteosarcoma patients.
about
UK guidelines for the management of bone sarcomasUK Guidelines for the Management of Bone Sarcomas.A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investmentGemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of boneOrthopaedic research in italy: state of the art.Review of management issues in relapsed osteosarcoma.The role of chemotherapy for metastatic, relapsed and refractory osteosarcoma.Advances in emerging drugs for osteosarcoma.An update on chemotherapy for osteosarcoma.Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patients.The importance of standardized treatment in high-grade osteosarcoma: 30 years of experience from a hospital-based database.Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS).Comparison of pirarubicin-based versus gemcitabine-docetaxel chemotherapy for relapsed and refractory osteosarcoma: a single institution experience.Evaluation of pirarubicin-cisplatin chemotherapy in the treatment for refractory and recurrent high-grade osteosarcoma: experience of a single institute.Progress in the chemotherapeutic treatment of osteosarcoma
P2860
Q26752425-C66693DA-3CEC-4CF9-9A4D-2FB4C83263ADQ34496992-52FAEB79-DC10-478D-835F-3B6F1299E130Q34628840-A4222DAC-05CE-4D7D-AD04-738936CD040DQ35958048-13375575-96EF-4CBF-AC49-7185CA16C6EFQ35995283-DEB796B4-05D9-44C0-80EE-24420B979A81Q37888852-EE3EB2D0-575B-4CA8-AC83-0F22632B3919Q38168922-F9EC847D-21F2-4466-9735-2D42217A08B5Q38267782-86E61E0B-1DEE-43BE-B06E-32654C541EF8Q38506118-9B4A9488-D41F-494D-8F11-40DFE35E086EQ38619114-B570B20D-16A3-4FBF-A741-F8A5C2E6CE1BQ38791215-D1CE8915-76E6-4B6D-A968-2D062F95C8C9Q44534585-329E4109-735E-4DDB-AF53-579199112867Q47633318-F6CF123D-48CC-4C55-9099-3C3B15C55B8DQ47851380-5A2B6126-B515-4203-9776-34CA8E47CDA8Q51021522-2FAAD3CA-F278-48BD-AF10-6F9D8F5E376AQ58572917-525BA99D-9F92-4931-BE05-721F4C7DD68D
P2860
Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high-risk osteosarcoma patients.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Phase 2 trial of two courses o ...... gh-risk osteosarcoma patients.
@ast
Phase 2 trial of two courses o ...... gh-risk osteosarcoma patients.
@en
Phase 2 trial of two courses o ...... gh-risk osteosarcoma patients.
@nl
type
label
Phase 2 trial of two courses o ...... gh-risk osteosarcoma patients.
@ast
Phase 2 trial of two courses o ...... gh-risk osteosarcoma patients.
@en
Phase 2 trial of two courses o ...... gh-risk osteosarcoma patients.
@nl
prefLabel
Phase 2 trial of two courses o ...... gh-risk osteosarcoma patients.
@ast
Phase 2 trial of two courses o ...... gh-risk osteosarcoma patients.
@en
Phase 2 trial of two courses o ...... gh-risk osteosarcoma patients.
@nl
P2093
P356
P1433
P1476
Phase 2 trial of two courses o ...... gh-risk osteosarcoma patients.
@en
P2093
A Brach del Prever
G Grignani
M Aglietta
S Aliberti
P304
P356
10.1002/CNCR.24368
P407
P577
2009-07-01T00:00:00Z